SCHEMBL26564790

SCHEMBL26564790

COc1ccc(/C=C/C(=O)OC(C)(C)C)cc1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.55
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
HPGD P15428 3/20 0.51
MAPK1 P28482 2/20 0.51
HSD17B10 Q99714 2/20 0.51
ALOX15 P16050 1/20 0.51
KMT2A Q03164 5/20 0.51
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
MAPT P10636 1/20 0.48
FDPS P14324 2/20 0.48
EPHX2 P34913 1/20 0.48
ESR1 P03372 1/20 0.47
MEN1 O00255 3/20 0.47
TP53 P04637 2/20 0.47
CYP3A4 P08684 2/20 0.47
HIF1A Q16665 2/20 0.47
PDE4D Q08499 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25283139 1.00 APP (0.55) APPALDH1A1KDM4ESMN1; SMN2HPGD
SCHEMBL31079444 0.89 KMT2A (0.51) ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1
SCHEMBL17002753 0.89 KMT2A (0.51) ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1
SCHEMBL30288730 0.89 KMT2A (0.51) ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1
SCHEMBL17002751 0.89 KMT2A (0.51) ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1
SCHEMBL3920819 0.89 ALDH1A1 (0.51) ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1
SCHEMBL3920813 0.89 ALDH1A1 (0.51) ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1
SCHEMBL25141958 0.83 APP (0.59) APPALDH1A1KDM4EHPGDMAPK1
SCHEMBL30487467 0.82 TUBB1 (0.59) ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1
SCHEMBL20158247 0.82 TUBB1 (0.59) ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331663-A1 SMALL MOLECULE NICOTINAMIDE ADENINE DINUCLEOTIDE MODULATORS THE CLEVELAND CLINIC FOUNDATION 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331663-A1 SMALL MOLECULE NICOTINAMIDE ADENINE DINUCLEOTIDE MODULATORS NQO1, NADK, CD38 APP 2497/4885ALDH1A1 158/4885KDM4E 3021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.